8-K - Emergent BioSolutions Inc. (0001367644) (Filer)
Published . Updated .
8-K - Emergent BioSolutions filed an 8-K with the SEC on Nov 2 (a notice of a material company event).
Directly affected
- EBS Emergent BioSolutions+6.5% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Emergent BioSolutions belongs to, so it often moves with news about it.
- LLY Eli Lilly and+21.6% 30d
Eli Lilly and is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson+1.5% 30d
Johnson & Johnson is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+11.4% 30d
AbbVie is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+3.2% 18d
Merck is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories+3.1% 30d
Abbott Laboratories is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| EBS | +3.74% | +12.54% | base | after close | after close | after close | after close |
| XLV | -3.14% | -0.51% | base | after close | after close | after close | after close |
| LLY | -9.70% | -3.22% | base | after close | after close | after close | after close |
| JNJ | -1.08% | +1.28% | base | after close | after close | after close | after close |
| ABBV | -0.84% | +0.67% | base | after close | after close | after close | after close |
| MRK | -4.78% | -1.78% | base | after close | after close | after close | after close |
| ABT | -6.49% | -5.19% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-11-02 AccNo: 0001367644-26-000110 Size: 6 MB Item 2.02: Results of Operations and Financial Condition Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
The price since 2 Nov 2026: Emergent BioSolutions (EBS) versus the S&P 500
| Company | When | Move | Status |
|---|---|---|---|
| AbbVie (ABBV) | three days earlier | +0.67% | final price |
| AbbVie (ABBV) | five days earlier | -0.84% | final price |
| Abbott Laboratories (ABT) | three days earlier | -5.19% | final price |
| Abbott Laboratories (ABT) | five days earlier | -6.49% | final price |
| Emergent BioSolutions (EBS) | three days earlier | +12.54% | final price |
| Emergent BioSolutions (EBS) | five days earlier | +3.74% | final price |
| Johnson & Johnson (JNJ) | three days earlier | +1.28% | final price |
| Johnson & Johnson (JNJ) | five days earlier | -1.08% | final price |
| Eli Lilly (LLY) | three days earlier | -3.22% | final price |
| Eli Lilly (LLY) | five days earlier | -9.70% | final price |
| Merck (MRK) | three days earlier | -1.78% | final price |
| Merck (MRK) | five days earlier | -4.78% | final price |
| Select Sector Spdr Tr (XLV) | three days earlier | -0.51% | final price |
| Select Sector Spdr Tr (XLV) | five days earlier | -3.14% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 38 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 55 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 49 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 39 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 75 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 31 days before publication. Filed 27 Oct 2026. View the filing.
- Rep. Gilbert Cisneros bought Abbott Laboratories (ABT), worth $1,001 - $15,000 on 18 Sep 2026. That is 45 days before publication. Filed 12 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Abbott Laboratories (ABT) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 59 days before publication. Filed 7 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
Who gains and who loses around Emergent BioSolutions (EBS)
Companies tied to this story
- EBS Emergent BioSolutions
For “8-K - Emergent BioSolutions Inc. (0001367644) (Filer),” Emergent BioSolutions (EBS) is linked, with no stored direction, high confidence. Reason on file: SEC 8-K filing -> direct issuer disclosure -> EBS
- XLV Select Sector Spdr Tr
In “8-K - Emergent BioSolutions Inc. (0001367644) (Filer),” Select Sector Spdr Tr (XLV) is linked, with no stored direction, medium confidence. Reason on file: Health Care Select Sector SPDR holds the health sector that Emergent BioSolutions belongs to, so it often moves with news about it
- LLY Eli Lilly
Eli Lilly (LLY) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Emergent BioSolutions Inc. (0001367644) (Filer).” Reason on file: Eli Lilly and is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news
- JNJ Johnson & Johnson
Johnson & Johnson (JNJ) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Emergent BioSolutions Inc. (0001367644) (Filer).” Reason on file: Johnson & Johnson is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news
- ABBV AbbVie
AbbVie (ABBV) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Emergent BioSolutions Inc. (0001367644) (Filer).” Reason on file: AbbVie is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news
- MRK Merck
Merck (MRK) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Emergent BioSolutions Inc. (0001367644) (Filer).” Reason on file: Merck is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news
- ABT Abbott Laboratories
Abbott Laboratories (ABT) is linked, with no stored direction, medium confidence in the 2 Nov 2026 story “8-K - Emergent BioSolutions Inc. (0001367644) (Filer).” Reason on file: Abbott Laboratories is a peer of Emergent BioSolutions in pharmaceutical preparations; rivals often move on the same news
How “8-K - Emergent BioSolutions Inc. (0001367644) (Filer)” reaches Emergent BioSolutions (EBS)
On 2 Nov 2026, “8-K - Emergent BioSolutions Inc. (0001367644) (Filer)” is the story that connects Emergent BioSolutions (EBS) to this story.
For Emergent BioSolutions (EBS), the reason on file says SEC 8-K filing -> direct issuer disclosure -> EBS
Also listed, Select Sector Spdr Tr (XLV): Health Care Select Sector SPDR holds the health sector that Emergent BioSolutions belongs to, so it often moves with news about it
Dates and price levels for Emergent BioSolutions (EBS)
EBS traded between 6.02 and 7.34 across 17 sessions. The latest close on file is 6.79. LLY traded between 1131.55 and 1447.86 across 20 sessions. The latest close on file is 1415.62.
A simple score for Emergent BioSolutions (EBS)
46 out of 100
“8-K - Emergent BioSolutions Inc. (0001367644) (Filer)” scores 46 out of 100. The score uses 1 sources, and 7 linked companies.